Join the club for FREE to access the whole archive and other member benefits.

Wen Hwa Lee

CEO and Chief Scientist at Action Against AMD.

Lee is presently the CEO and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), the leading cause of legal blindness in developed world. AAAMD’s mission is to find and enable convenient, affordable, and accessible solutions – including new drugs - to stop AMD in its early stages, before it causes sight loss.

Trained in genetics and molecular/ structural biology, he is an experienced leader in setting up partnerships and alliances with multiple stakeholders to accelerate discoveries for drug discovery. Lee designed and implemented several open science strategies in two of the largest and most successful international public-private partnerships for drug discovery – the Structural Genomics Consortium (SGC) and the European Lead Factory. Alongside his scientific endeavours, Lee also advised high-level government representatives from different countries and charitable institutions on policy and strategy to integrate scientific, societal, and economic impact. Previously Lee directed the Disease Foundations Network at the Structural Genomics Consortium (SGC) – a pioneering open science initiative, at the University of Oxford.

Visit website: https://www.actionagainstamd.org/executive-team

 opendrugdiscovery

 wenhwalee

See also: Company Action Against AMD (AAAMD) - Non-profit organization dedicated to eradicating age-related macular degeneration.

Details last updated 17-Apr-2021

Wen Hwa Lee is also referenced in the following:

UK SPINE 2021 Annual conference

21-Apr-2021 to 23-Apr-2021

Series of events focused on research and innovation in geroscience and ageing therapeutics organized by UK SPINE.